8-K/A
Current Report
X4 Pharmaceuticals, Inc Filed Acc 0001193125-19-150552
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading d749947d8ka.htm…